.
.
What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
Petrini P. Petrini P.
. Gong J, et al. Brief Bioinform. 2021 Sep 2;22(5):bbaa427. doi: 10.1093/bib/bbaa427. Brief Bioinform. 2021. PMID: 33515024
.
- Gluten intolerance a significant risk factor
- Infectious disease of the uterus
- Absence of an individual specific disease